- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06284512
Uveal Melanoma - Comparative Study
February 21, 2024 updated by: Reinhard Told, Medical University of Vienna
Uveal Melanoma In Sonography and Color Fundus Photos - A Comparative Study
The progress of uveal melanoma is typically monitored with sonography by experienced onco-ophthalmologists.
However, there is evidence that twodimensional measurements in color fundus photography match precisely with sonography measurements.
This study aims to compare sonography and color fundus photography measurements in order to evaluate the feasibility of monitoring of uveal melanoma with color fundus photography.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Reinhard Told, MD, PhD, Priv.-Doz.
- Phone Number: +43 40400 79690
- Email: reinhard.told@meduniwien.ac.at
Study Contact Backup
- Name: Judith Kreminger, MD
- Phone Number: +43 40400 48470
- Email: judith.kreminger@meduniwien.ac.at
Study Locations
-
-
-
Vienna, Austria, 1090
- Recruiting
- Medical University of Vienna, Department of Ophthalmology and Optometry
-
Sub-Investigator:
- Adrian Reumueller, MD, Priv.-Doz
-
Contact:
- Judith Kreminger, MD
- Phone Number: +4314040048470
- Email: judith.kreminger@meduniwien.ac.at
-
Contact:
- Reinhard Told, MD, PhD, Priv.-Doz.
- Phone Number: +434040079690
- Email: reinhard.told@meduniwien.ac.at
-
Sub-Investigator:
- Roman Dunavölgyi, Assoc.-Prof. Priv.-Doz. Dr.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with uveal melanoma will be included in this study.
Description
Inclusion Criteria:
- Diagnosis of uveal melanoma
Exclusion Criteria:
- Inadequate or missing information on the clinical course in patient charts
- Imaging not feasible due to any reason.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Uveal Melanoma
Patients with uveal melanoma will undergo a routine diagnostic imaging with color fundus photography and sonography.
|
Patients will undergo routine diagnostic imaging (Sonography, color fundus photography)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Largest Basal Diameter
Time Frame: 1 day
|
Largest Basal Diameter will be measured on echography and color fundus photography
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Reinhard Told, MD, PhD, Priv.-Doz., Deparment of Ophthalmology and Optometry
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 15, 2023
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
October 12, 2023
First Submitted That Met QC Criteria
February 21, 2024
First Posted (Estimated)
February 29, 2024
Study Record Updates
Last Update Posted (Estimated)
February 29, 2024
Last Update Submitted That Met QC Criteria
February 21, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Uveal Melanoma 1942/2022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Uveal Melanoma
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedIris Melanoma | Medium/Large Size Posterior Uveal Melanoma | Stage IIA Uveal Melanoma | Stage IIB Uveal Melanoma | Stage IIIA Uveal Melanoma | Stage IIIB Uveal Melanoma | Stage IIIC Uveal MelanomaUnited States
-
National Cancer Institute (NCI)ExelisisCompletedStage IV Uveal Melanoma AJCC v7 | Recurrent Uveal Melanoma | Stage III Uveal Melanoma AJCC v7 | Stage IIIA Uveal Melanoma AJCC v7 | Stage IIIB Uveal Melanoma AJCC v7 | Stage IIIC Uveal Melanoma AJCC v7United States, Canada
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedStage IV Uveal Melanoma | Stage IIIA Uveal Melanoma | Stage IIIB Uveal Melanoma | Stage IIIC Uveal MelanomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Incyte Corporation; University of VirginiaCompletedStage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Mucosal Melanoma | Stage IV Uveal Melanoma | Stage IIIA Skin Melanoma | Stage IIIA Uveal Melanoma | Stage IIIB Uveal Melanoma | Stage IIIC Uveal Melanoma | Recurrent Uveal MelanomaUnited States
-
National Cancer Institute (NCI)CompletedIris Melanoma | Stage IV Uveal Melanoma | Medium/Large Size Posterior Uveal Melanoma | Recurrent Uveal Melanoma | Ocular Melanoma With Extraocular Extension | Small Size Posterior Uveal MelanomaUnited States, Canada
-
Alliance for Clinical Trials in OncologyWithdrawnMetastatic Uveal Melanoma | Advanced Uveal Melanoma | Unresectable Uveal Melanoma
-
National Cancer Institute (NCI)CompletedStage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Mucosal Melanoma | Iris Melanoma | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7 | Stage IV Uveal Melanoma AJCC v7 | Medium/Large Size Posterior Uveal Melanoma | Recurrent... and other conditionsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Thomas...PfizerActive, not recruitingSunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal MelanomaCiliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Stage IIIA Intraocular Melanoma | Stage IIIB Intraocular Melanoma | Stage IIIC Intraocular Melanoma | Stage I Intraocular Melanoma | Stage IIA Intraocular Melanoma | Stage IIB Intraocular... and other conditionsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteDelcath Systems Inc.RecruitingMetastatic Uveal MelanomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage IV Uveal Melanoma AJCC v7 | Recurrent Uveal MelanomaUnited States, France, United Kingdom
Clinical Trials on Sonography, color fundus photography
-
Pakistan Council of Scientific and Industrial ResearchAl-Ibrahim Eye HospitalRecruiting
-
URAL Telekomunikasyon San. Trade Inc.Not yet recruiting
-
Fondation Ophtalmologique Adolphe de RothschildCompletedStroke | Cerebrovascular AccidentsFrance
-
Heidelberg Engineering GmbHTerminatedNormal Eyes | Retinal VascularUnited States
-
Laurence PostelmansCompletedEpiretinal MembraneBelgium
-
University of Wisconsin, MadisonRecruitingAge-Related Macular DegenerationUnited States, Pakistan, Argentina, Australia, France, Germany, India
-
Heidelberg Engineering GmbHCompletedNormal Eyes | Retinal VascularUnited States
-
Topcon CorporationCompleted
-
University of MichiganWashington University School of Medicine; University of California, BerkeleyEnrolling by invitationGlaucoma | Diabetes Mellitus | Diabetic Retinopathy | Age Related Macular Degeneration | Retinal Disease | ROP
-
Semmelweis UniversityCompletedCilioretinal ArteriesHungary